These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35887521)

  • 21. Overcoming barriers to the adoption of locating technologies in dementia care: a multi-stakeholder focus group study.
    Freiesleben SD; Megges H; Herrmann C; Wessel L; Peters O
    BMC Geriatr; 2021 Jun; 21(1):378. PubMed ID: 34154542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An index of barriers for the implementation of personalised medicine and pharmacogenomics in Europe.
    Horgan D; Jansen M; Leyens L; Lal JA; Sudbrak R; Hackenitz E; Bußhoff U; Ballensiefen W; Brand A
    Public Health Genomics; 2014; 17(5-6):287-98. PubMed ID: 25401385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stakeholder Perspectives on Navigating Evidentiary and Decision Uncertainty in Precision Oncology.
    Pollard S; Dunne J; Costa S; Regier DA
    J Pers Med; 2022 Jan; 12(1):. PubMed ID: 35055337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bridging the Gaps in Personalized Medicine Value Assessment: A Review of the Need for Outcome Metrics across Stakeholders and Scientific Disciplines.
    Bush WS; Cooke Bailey JN; Beno MF; Crawford DC
    Public Health Genomics; 2019; 22(1-2):16-24. PubMed ID: 31454805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigating acceptability of a training programme in precision medicine for frontline healthcare professionals: a mixed methods study.
    Mitchell S; Jaccard E; Schmitz FM; von Känel E; Collombet P; Cornuz J; Waeber G; Guessous I; Guttormsen S
    BMC Med Educ; 2022 Jul; 22(1):556. PubMed ID: 35850770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 27. Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative.
    Trosman JR; Weldon CB; Douglas MP; Kurian AW; Kelley RK; Deverka PA; Phillips KA
    J Natl Compr Canc Netw; 2017 Feb; 15(2):219-228. PubMed ID: 28188191
    [No Abstract]   [Full Text] [Related]  

  • 28. A logic model for precision medicine implementation informed by stakeholder views and implementation science.
    Chanfreau-Coffinier C; Peredo J; Russell MM; Yano EM; Hamilton AB; Lerner B; Provenzale D; Knight SJ; Voils CI; Scheuner MT
    Genet Med; 2019 May; 21(5):1139-1154. PubMed ID: 30353149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The First National Pain Medicine Summit--final summary report.
    Lippe PM; Brock C; David J; Crossno R; Gitlow S
    Pain Med; 2010 Oct; 11(10):1447-68. PubMed ID: 21199301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USA.
    Janssens R; Russo S; van Overbeeke E; Whichello C; Harding S; Kübler J; Juhaeri J; Bywall KS; Comanescu A; Hueber A; Englbrecht M; Nikolenko N; Pravettoni G; Simoens S; Stevens H; Hermann R; Levitan B; Cleemput I; de Bekker-Grob E; Veldwijk J; Huys I
    Patient; 2019 Oct; 12(5):513-526. PubMed ID: 31222436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicians' Perceptions towards Precision Medicine Tools for Cardiovascular Disease Risk Stratification in South Africa.
    Kamp M; Pain O; May A; Lewis CM; Ramsay M
    J Pers Med; 2022 Aug; 12(9):. PubMed ID: 36143145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adoption of Electronic Personal Health Records in Canada: Perceptions of Stakeholders.
    Gagnon MP; Payne-Gagnon J; Breton E; Fortin JP; Khoury L; Dolovich L; Price D; Wiljer D; Bartlett G; Archer N
    Int J Health Policy Manag; 2016 Jul; 5(7):425-433. PubMed ID: 27694670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Payer Preferences and Willingness to Pay for Genomic Precision Medicine: A Discrete Choice Experiment.
    Dhanda DS; Veenstra DL; Regier DA; Basu A; Carlson JJ
    J Manag Care Spec Pharm; 2020 Apr; 26(4):529-537. PubMed ID: 32223606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolving Perceptions, Utilization, and Real-World Implementation Experiences of Oncology Monoclonal Antibody Biosimilars in the USA: Perspectives from Both Payers and Physicians.
    Yang J; Blinzler K; Lankin J; Vijayakumar S; Maculaitis MC; Shelbaya A
    BioDrugs; 2022 Jan; 36(1):71-83. PubMed ID: 34822141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural racism in precision medicine: leaving no one behind.
    Geneviève LD; Martani A; Shaw D; Elger BS; Wangmo T
    BMC Med Ethics; 2020 Feb; 21(1):17. PubMed ID: 32075640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustainable Adoption of Digital Health Innovations: Perspectives From a Stakeholder Workshop.
    Van Velthoven MH; Cordon C
    J Med Internet Res; 2019 Mar; 21(3):e11922. PubMed ID: 30907734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacogenomic-based personalized medicine: Multistakeholder perspectives on implementational drivers and barriers in the Canadian healthcare system.
    Subasri M; Barrett D; Sibalija J; Bitacola L; Kim RB
    Clin Transl Sci; 2021 Nov; 14(6):2231-2241. PubMed ID: 34080317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing-Based Tests: Challenges, Opportunities, and Potential Solutions.
    Deverka PA; Douglas MP; Phillips KA
    Value Health; 2020 May; 23(5):540-550. PubMed ID: 32389218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Payer perceptions on the use of patient-reported outcomes in oncology decision making.
    Oderda G; Brixner D; Biskupiak J; Burgoyne D; Arondekar B; Deal LS; Quek RG; Niyazov A
    J Manag Care Spec Pharm; 2022 Feb; 28(2):188-195. PubMed ID: 34806908
    [No Abstract]   [Full Text] [Related]  

  • 40. Engaging multilevel stakeholders in an implementation trial of evidence-based quality improvement in VA women's health primary care.
    Hamilton AB; Brunner J; Cain C; Chuang E; Luger TM; Canelo I; Rubenstein L; Yano EM
    Transl Behav Med; 2017 Sep; 7(3):478-485. PubMed ID: 28585163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.